Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 7, 2015; 21(21): 6604-6612
Published online Jun 7, 2015. doi: 10.3748/wjg.v21.i21.6604
Published online Jun 7, 2015. doi: 10.3748/wjg.v21.i21.6604
Table 1 Clinical characteristics
| Controls, n | PaC, n | |
| All | 99 | 84 |
| Male | 46 | 45 |
| Female | 53 | 39 |
| Caucasian | 75 | 77 |
| African American | 23 | 6 |
| Other | 1 | 1 |
| Age (yr), median | 45 (19-85) | 64 (41-96) |
| TNM Stage | ||
| I/II | 11 | |
| III/IV | 23 | |
| Stage unknown | 50 | |
| Surgery | ||
| Sample collected prior to surgery | 38 | |
| Sample collected after surgery | 23 | |
| NA | 23 | |
| Chemo | ||
| Sample collected prior to chemo | 6 | |
| Sample collected after chemo | 17 | |
| Sample collected during chemo | 56 | |
| NA | 5 | |
| Radiation | ||
| Sample collected prior radiation | 47 | |
| Sample collected after radiation | 11 | |
| Sample collected during radiation | 3 | |
| NA | 23 |
- Citation: Ritchie SA, Chitou B, Zheng Q, Jayasinghe D, Jin W, Mochizuki A, Goodenowe DB. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9. World J Gastroenterol 2015; 21(21): 6604-6612
- URL: https://www.wjgnet.com/1007-9327/full/v21/i21/6604.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i21.6604